Yawning and stretching induced by transcranial application of ac pulsed electromagnetic fields in Parkinson's disease

International Journal of Neuroscience

Volumn 97, Issue 1-2, 1999, Pages 139-145

  Sandyk, Reuven ^a,b  

^a TOURO COLLEGE   (United States)

^b NONE   (United States)

Author keywords

ACTH MSH peptides; Dopamine; Dopamine D2 receptors; Electromagnetic fields; Parkinson's disease; Stretching; Yawning

Indexed keywords

EID: 0033103788     PISSN: 00207454     EISSN: None     Source Type: Journal    
DOI: 10.3109/00207459908994308     Document Type: Article

References (34)

1. Anias, J., Holmgren, B., Urba Holmgren, R. & Eguibar, J. R. (1984) Circadian variation of yawning behavior. Acta Neurobiologica Experimentale (Warsz.), 44, 179-186.
2. Argiolas, A. & Melis, M. R. (1998) The neuropharmacology of yawning. European Journal of Pharmacology, 343, 1-16.
3. Baenninger, R., Binkley, S. & Baenninger, M. (1996) Field observations of yawning and activity in humans. Physiology & Behavior, 59, 421-425.
4. Bertolini, A. & Gessa, G. L. (1981) Behavioral effects of ACTH and MSH peptides. Journal of Endocrine Investigation, 4, 241-251.
5. Boshes, B. (1969). Syndromes of the diencephalon. In: Vinken, J. P. and Bruyn, G. W. (Eds.), Handbook of clinical neurology: Localization in clinical neurology, Vol. 2 (p.450). Amsterdam: Elsevier.
6. Concu, A., Ferrari, W., Gessa, G. L., Mereu, G. P. & Tagliamonte, A. (1974) EEG changes induced by the intraventricular injection of ACTH in cats. In: Levin, P. and Koella, W. P. (Eds.), Sleep (p. 321), Basel: Karger.
7. 2 agonist N-0437 is blocked by the selective dopamine autoreceptor antagonist (+)-UH 232. Physiology & Behavior, 45, 1263-1266.
8. DeJong, R. N. (1979) The neurologic examination (p. 237). Philadelphia: Harper & Row.
9. D'Mello, D. A., Vincent, F. M. & Lerner, M. P. (1988) Yawning as a complication of electroconvulsive therapy and concurrent neuroleptic withdrawal. Journal of Nervous and Mental Disease, 176, 188-189.
10. Dourish, C. T. & Cooper, S. J. (1985) Behavioral evidence for the existence of dopamine autoreceptors. Trends in Pharmacological Sciences, 6, 17-24.
11. Ferrari, W. (1958) Behavioral changes in animals after intracisternal injection with adrenocorticotrophic hormone and melanocyte stimulating hormone. Nature, 181, 925-926.
12. Ferrari, W., Gessa, G. L. & Vargiu, L. (1963) Behavioral effects induced by intracisternally injected ACTH and MSH. Annals of the New York Academy of Sciences, 104, 330-345.
13. Floris, E. (1963) Effects of intraspinal injection of ACTH in man. Bulletin of the Society of Italien Biology, 39, 558-560.
14. Gershanik, O., Heikkila, R. E. & Duvoisin, R. C. (1983). Behavioral correlations of dopamine receptor activation. Neurology, 33, 1489-1492.
15. Gessa, G. L., Pisano, M., Vargiu, L., Carbai, F. & Ferrari, W. (1967) Stretching and yawning movements after intracerebral injection of ACTH. Revue Canadienne Biologique, 26, 229-236.
16. Goren, J. L. & Friedman, J. H. (1998) Yawning as an aura for an L-dopa-induced "on" in Parkinson's disease. Neurology, 50, 823.
17. Kebabian, J. W. & Calne, D. B. (1979) Multiple receptors for dopamine, Nature, 277, 93-96.
18. Lehmann, H. E. (1979) Yawning: a homeostatic reflex and its psychological significance. Bulletin of the Menninger Clinic, 43, 123-136.
19. Longoni, R., Spina, L. & Di Chiara, G. (1987) Permissive role of D-1 receptor stimulation by endogenous dopamine for the expression of postsynaptic D-2 mediated behavioral responses. European Journal of Pharmacology, 134, 163-173.
20. Mogilnicka, E. & Kilmek, V. (1977) Drugs affecting dopamine neurones and yawning behaviour. Pharmacology Biochemistry and Behavior, 1, 303-305.
21. Mora, S. & Diaz-Veliz, G. (1989) LHRH antagonizes yawning and genital grooming induced by apomorphine in rats. Pharmacology Biochemistry & Behavior, 31, 717-720.
22. Reynolds, G. P. & Riederer, P. (1990) The neuropharmacology of Parkinson's disease. In: Stern, G. (Ed.), Parkinson's disease (pp. 127- 149). London: Chapman and Hall Medical.
23. Rollinson, R. D., Wiggins, W. S. & Gilligan, B. S. (1979) Drug-induced yawning successfully treated with pimozide. Archives of Neurology, 36, 253.
24. Sandyk, R. (1995) Cholinergic mechanisms in Gilles de la Tourette's syndrome. International Journal of Neuroscience, 81, 95-100.
25. Sandyk, R. (1997) The biological significance of yawning elicited by application of electromagnetic fields in multiple sclerosis. International Journal of Neuroscience, 89, 53-60.
26. Schachter, M., Bedard, P., Debono, A. G., Jenner, P., Marsden, C. D., Rosenthaler, J., Horowski, R. & Dorow, R. (1981) The role of D-1 and D-2 receptors. Nature, 286, 157-159.
27. Serra, G., Collu, M. & Gessa, G. L. (1986) Dopamine receptors mediating yawning: are they autoreceptors? European Journal of Pharmacology, 120, 187-192.
28. Serra, G., Collu, M. & Gessa, G. L. (1987) Yawning is elicited by D2 dopamine agonists but is blocked by the D1 antagonist, SCH 23390. Psychopharmacology, 91, 330-333.
29. Stahle, L. & Ungerstedt, U. (1984) Assessment of dopamine autoreceptor agonist properties of apomorphine, (+) 3-PPP, and (-) 3-PPP by recording of yawning behavior in rats. European Journal of Pharmacology, 98, 307-310.
30. Szechtman, H., Cleghorn, J. M., Brown, G. M., Kaplan, R. D., Franco, S. & Rosenthal, K. (1988) Sensitization and tolerance to apomorphine in men: yawning, growth hormone, nausea and hyperthermia. Psychiatry Research, 23, 245-255.
31. Urba-Holmgren, R., Holmgren, B., Rodriguez, R. & Gonzalez, R. M. (1979) Serotonergic modulation of yawning. Pharmacology Biochemistry & Behavior, 11, 371-372.
32. Yamada, K. & Furukawa, T. (1980) Direct evidence for involvement of dopaminergic inhibition and cholinergic activation of yawning. Psychopharmacology, 67, 39-43.
33. Zarrindast, M. R., Toloui, V. & Hashemi, B. (1995a) Effect of GABA-ergic drugs on physostigmine-induced yawning in rats. Psychopharmacology (Berlin), 122, 297-300.
34. Zarrindast, M. R., Fatehi, F. & Mohagheghi-Badi, M. (1995b) Effects of adenosine agents on apomorphine-induced yawning in rats. Psychopharmacology, 122, 292-296.